60°
Baton Rouge, Louisiana
7 Day Forecast

Latest Weather Blog

Follow our weather team on social media

FDA panel backs female libido pill with safety conditions

1 year 6 months 14 hours ago June 04, 2015 Jun 4, 2015 Thursday, June 04 2015 June 04, 2015 3:51 PM in Health
Source: Associated Press
By: Matthew Perrone

WASHINGTON  - Government health experts are backing an experimental drug intended to boost the female sex drive, but stress that it must carry safety restrictions to manage side effects including fatigue, low blood pressure and fainting.

The Food and Drug Administration panel voted 18-6 in favor of approving Sprout Pharmaceutical's daily pill flibanserin, on the condition that its manufacturer develops a plan to limit safety risks.

The positive recommendation is a major victory for a drug sometimes hailed as "female Viagra," but which has been plagued by for years by concerns about its lackluster effectiveness and safety issues. The FDA has twice rejected the drug since 2010.

More News

Desktop News

Click to open Continuous News in a sidebar that updates in real-time.
Radar
7 Days